Published in Dtsch Med Wochenschr on June 28, 1985
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) Clin Exp Immunol (1995) 4.81
European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology (1984) 4.09
Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci (1981) 2.36
Endoscopic papillary dilation (EPD) for the treatment of common bile duct stones and papillary stenosis. Endoscopy (1983) 2.05
Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis. Aliment Pharmacol Ther (1998) 1.47
Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease. Gastroenterology (1993) 1.43
Gastrointestinal pH profiles in patients with inflammatory bowel disease. Aliment Pharmacol Ther (1998) 1.17
Endoscopic papillary dilatation, a possible alternative to endoscopic papillotomy. Lancet (1982) 1.16
Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease. Gut (1983) 1.16
Effect of glyceryl trinitrate on the sphincter of Oddi motility and baseline pressure. Gut (1985) 1.10
Fecal blood loss in patients with colonic polyps: a comparison of measurements with 51chromium-labeled erythrocytes and with the Haemoccult test. Gastroenterology (1982) 1.09
Mechanical gallstone lithotripsy in the common bile duct--in-vitro and in-vivo experience. Endoscopy (1983) 0.95
Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III. Scand J Gastroenterol (1990) 0.95
Factitious diarrhoea. Clin Gastroenterol (1986) 0.93
Alteration of esophageal peristalsis by pentagastrin in patients with diffuse esophageal spasm. Scand J Gastroenterol (1975) 0.90
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group. Eur J Gastroenterol Hepatol (1996) 0.88
Bacteremia after proctoscopy and hemorrhoidal injection sclerotherapy. Dis Colon Rectum (1981) 0.87
n-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci (1996) 0.87
[The early recurrence of Crohn's disease after "curative" ileocecal resection. A prospective endoscopic and histological study]. Dtsch Med Wochenschr (1990) 0.87
Antiinflammatory treatment and intestinal alpha 1-antitrypsin clearance in active Crohn's disease. Dig Dis Sci (1985) 0.86
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group. Gut (1998) 0.86
[Endoscopic papillary dilatation: an alternative to papillotomy? (author's transl)]. Dtsch Med Wochenschr (1982) 0.85
[The treatment of irritable colon. Efficacy and tolerance of buscopan plus, buscopan, paracetamol and placebo in ambulatory patients with irritable colon]. Fortschr Med (1990) 0.84
[Spermatogram evaluation in cases with Crohn disease]. Andrologia (1981) 0.84
Antibodies to cytoskeletal proteins in patients with Crohn's disease. Eur J Clin Invest (1990) 0.84
[Enteropathic spondylarthritis in chronic inflammatory bowel diseases: prevalence, manifestation pattern and HLA association]. Med Klin (Munich) (1996) 0.84
[Resorption and secretion of calcium in the human jejunum]. Klin Wochenschr (1968) 0.83
Letter: Prevention of post-transfusion hepatitis. Lancet (1974) 0.83
[Extent of drug compliance in Crohn disease patients--study of a special ambulatory care unit of a university clinic]. Z Gastroenterol (1984) 0.82
Endoscopic balloon tamponade for conservative management of severe hemorrhage following endoscopic sphincterotomy. Z Gastroenterol (1984) 0.82
Corticosteroids for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev (2003) 0.81
Assessment of various factors influencing esophageal pressure measurement. II. Significance of physiological factors in intraluminal manometry. Klin Wochenschr (1980) 0.81
[The effect of a diphenolic laxative (Bisacodyl) on water- and electrolyte transport in the human colon (author's transl)]. Klin Wochenschr (1974) 0.81
Nitroglycerine dilatation of sphincter of Oddi for endoscopic removal of bileduct stones. Lancet (1984) 0.81
[Pancreatitis associated with 5-aminosalicylic acid]. Dtsch Med Wochenschr (1991) 0.80
IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases. Eur J Gastroenterol Hepatol (2000) 0.80
Corticosteroids for maintaining remission of Crohn's disease. Cochrane Database Syst Rev (2001) 0.79
The physiological basis of laxative action. Pharmacology (1980) 0.79
Treatment of active Crohn's disease with an oral slow-release budesonide formulation. Am J Gastroenterol (1993) 0.79
Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Germany Budesonide Study Group. Z Gastroenterol (1995) 0.79
Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group. Hepatogastroenterology (1997) 0.78
Pentazocine hampers bile flow. Lancet (1985) 0.78
Calcium and magnesium transport and influence of 1,25-dihydroxyvitamin D3. In vivo perfusion study at the colon of the rat. Digestion (1987) 0.77
Anti-TNF antibody in Crohn's disease--status of information, comments and recommendations of an international working group. Z Gastroenterol (1999) 0.77
[(Quality of semen in patients with Crohn's disease) ]. Z Gastroenterol (1982) 0.77
Assessment of various factors influencing esophageal pressure measurement. I. Significance of methodical factors in intraluminal manometry. Klin Wochenschr (1980) 0.77
Influence of loperamide and loperamide oxide on the anal sphincter. A manometric study. Dis Colon Rectum (1992) 0.76
Esophageal dysfunction and its pathogenesis in progressive systemic sclerosis. Klin Wochenschr (1978) 0.75
Investigation of the sphincter of Oddi before, immediately after and six weeks after endoscopic papillotomy. Endoscopy (1986) 0.75
[Manometric study of esophageal involvement in progressive systemic sclerosis (author's transl)]. Arch Dermatol Res (1975) 0.75
[Opium drops in diarrhea caused by Crohn disease]. Dtsch Med Wochenschr (1997) 0.75
Effect of intravenous diazepam on human lower oesophageal sphincter pressure under controlled double blind crossover conditions. Gut (1979) 0.75
Fecal alpha 1-antitrypsin in newborn infants. J Pediatr Gastroenterol Nutr (1997) 0.75
Effect of the artificially elevated common bile duct pressure on the motor activity and function of the papilla of Vater. A study by endoscopic manometry. Digestion (1985) 0.75
Metabolism of albumin in cirrhosis studied by a double-isotope technique. Digestion (1968) 0.75
[Precancerous conditions in the upper gastrointestinal tract. Diagnosis and monitoring]. Dtsch Med Wochenschr (1985) 0.75
Diarrhoea and constipation. Baillieres Clin Gastroenterol (1988) 0.75
Enteric protein loss in various gastrointestinal diseases determined by intestinal alpha 1-antitrypsin clearance. Z Gastroenterol (1989) 0.75
[Determination of intestinal inflammatory activity in Crohn disease using alpha 1-antitrypsin]. Dtsch Med Wochenschr (1985) 0.75
[Chronic inflammatory bowel diseases: scientifically interesting--also clinically relevant?]. Z Gastroenterol Verh (1989) 0.75
[Radical operation and recurrence prevention with azulfidine in Crohn disease: a prospective multicenter study--initial results]. Langenbecks Arch Chir (1984) 0.75
Corticosteroids for maintaining remission of Crohn's disease. Cochrane Database Syst Rev (2000) 0.75
Effect of 4 x 250 mg erythromycin on human gastrointestinal transit. Z Gastroenterol (1995) 0.75
[Abuse of laxatives]. Internist (Berl) (1986) 0.75
[Endoscopic gallstone extraction through the intact bile duct sphincter after drug-induced dilatation of Vater's ampulla]. Schweiz Rundsch Med Prax (1986) 0.75
Comparison of maximal postprandial serum cholylglycine concentration with the retention of 75Se-homotaurocholic acid in ileal dysfunction. Z Gastroenterol (1989) 0.75
Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial. Dig Dis Sci (2003) 0.75
[ERCP using a new contrast catheter movable in all directions. An aid in typical ERCP problems]. Schweiz Rundsch Med Prax (1984) 0.75
[Gastric acidity determination with the endoradiosonde (Heidelberg capsule) in comparison with the histological findings of the mucous membrane and maximum histamine test]. Dtsch Med Wochenschr (1968) 0.75
[Endoscopic assessment of esophageal variceal pressure]. Schweiz Rundsch Med Prax (1984) 0.75
Computed tomography to predict hardness of bileduct stones before endoscopic lithotripsy. Lancet (1984) 0.75
[Defined formula diet in the treatment of active Crohn disease]. Beitr Infusionther Klin Ernahr (1986) 0.75
[Modification of iron absorption in the small intestine by complex formation with 8-hydroxyquinoline and its sulfonate. Perfusion studies of the human jejunum]. Klin Wochenschr (1968) 0.75
Intraindividual variability of anorectal manometry parameters. Z Gastroenterol (1992) 0.75
ERCP using a special catheter with external steering. A reliable aid in typical ERCP problems. Endoscopy (1985) 0.75
[Balloon tamponade in acute hemorrhage following endoscopic papillotomy]. Schweiz Rundsch Med Prax (1986) 0.75
Simplified determination of intestinal protein excretion based on alpha 1-antitrypsin clearance. Z Gastroenterol (1988) 0.75
[New developments and trends in the drug therapy of chronic inflammatory bowel diseases]. Verh Dtsch Ges Inn Med (1988) 0.75
[Arteriographic demonstration and surgical management of an ulcerogenic pancreatic tumor. (Zollinger-Ellison syndrome)]. Dtsch Med Wochenschr (1969) 0.75
[Therapy of acute infectious diarrhea]. Dtsch Med Wochenschr (1983) 0.75
[Refractory forms of constipation]. Verh Dtsch Ges Inn Med (1988) 0.75
[The Gastroenterologic Oncology Study Group]. Z Gastroenterol Verh (1988) 0.75
Postprandial cholylglycine serum concentration and extent of ileal inflammation or resection in Crohn's disease. Digestion (1986) 0.75
[Endoscopic papillary and bile duct manometry in evaluating the function of Vater's papilla. Studies on patients with cholecystolithiasis]. Schweiz Rundsch Med Prax (1984) 0.75
[Increased serum alpha 1-antitrypsin does not produce a rise in fecal alpha 1-antitrypsin in patients with healthy intestines]. Z Gastroenterol (1991) 0.75
[Fecal inflammatory markers in Crohn disease]. Z Gastroenterol Verh (1989) 0.75
[Therapy with antacids: dyspepsia with and without ulcer]. Z Gastroenterol (1983) 0.75
[Diversion colitis in Crohn disease. A case report and review of the literature]. Z Gastroenterol (1989) 0.75
[Pathogenesis of chronic inflammatory bowel diseases]. Z Gastroenterol Verh (1983) 0.75
Effect of loperamide on jejunal electrolyte and water transport, prostaglandin E2-induced secretion and intestinal transit time in man. Eur J Clin Pharmacol (1991) 0.75
[GAVE syndrome: a rare cause of occult gastrointestinal hemorrhage]. Pathologe (1992) 0.75
[Crohn disease: when conservative, when surgical treatment?]. Dtsch Med Wochenschr (1984) 0.75
[Amebic colitis - differential diagnosis of ulcerative colitis and Crohn disease]. Z Gastroenterol (1984) 0.75
[Spontaneous cholecystocolic fistula]. Med Welt (1969) 0.75